methotrexate has been researched along with Pyoderma Gangrenosum in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Bhowmick, K; Dey, S; Ghosh, B; Ghosh, P; Mondal, S; Roongta, R; Sinhamahapatra, P | 1 |
| Micheletti, RG; Wang, LL | 1 |
| Agarwal, P; Agarwal, US; Prakash, C; Sharma, P | 1 |
| Cains, GD; Lin, P; Vekic, DA; Woods, J | 1 |
| Chua, EP; Dahiya, S; Mallett, RB | 1 |
| Bajaj, S; Bose, SK; Sardana, K | 1 |
| Katsambas, A; Koumantaki-Mathioudaki, E; Rallis, E; Stavropoulos, P; Tsiatoura, A | 1 |
| Androutsakos, T; Aroni, K; Hatzis, G; Stamopoulos, P | 1 |
| Agrawal, S; Chandrasekhara, PK; Jayachandran, NV; Narsimulu, G; Thomas, J | 1 |
| Graham, V; Mittal, S | 1 |
| Nordstrom, D | 1 |
| Teitel, AD | 1 |
| Hargadon, AP; Phan, JC; Salpeter, SR | 1 |
3 review(s) available for methotrexate and Pyoderma Gangrenosum
| Article | Year |
|---|---|
Refractory Takayasu arteritis with recurrent pyoderma gangrenosum: a therapeutic challenge with case-based review.
Topics: Adult; Female; Humans; Immunosuppressive Agents; Methotrexate; Prednisolone; Pyoderma Gangrenosum; Takayasu Arteritis; Young Adult | 2023 |
SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literature.
Topics: Acquired Hyperostosis Syndrome; Adalimumab; Adult; Anti-Inflammatory Agents; Dermatologic Agents; Drug Therapy, Combination; Hidradenitis Suppurativa; Humans; Male; Methotrexate; Pyoderma Gangrenosum | 2018 |
A case report of successful treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis, and review of the literature.
Topics: Anti-Inflammatory Agents; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Methotrexate; Prednisolone; Pyoderma Gangrenosum; Young Adult | 2015 |
10 other study(ies) available for methotrexate and Pyoderma Gangrenosum
| Article | Year |
|---|---|
Low-dose methotrexate as rescue therapy in patients with hidradenitis suppurativa and pyoderma gangrenosum developing human antichimeric antibodies to infliximab: A retrospective chart review.
Topics: Adult; Aged; Antibody Formation; Female; Hidradenitis Suppurativa; Humans; Infliximab; Male; Methotrexate; Middle Aged; Pyoderma Gangrenosum; Retrospective Studies | 2020 |
Ulcerative Pyoderma Gangrenosum and Leukocytoclastic Vasculitis in a Hypothyroid Woman: A Case Report.
Topics: Azathioprine; Drug Therapy, Combination; Female; Humans; Hypothyroidism; Immunosuppressive Agents; Methotrexate; Middle Aged; Pyoderma Gangrenosum; Remission Induction; Vasculitis, Leukocytoclastic, Cutaneous | 2017 |
Cogan's syndrome with pyoderma gangrenosum: management of two uncommon disorders with aggressive presentation in a patient.
Topics: Administration, Intravenous; Azathioprine; Biopsy; Cogan Syndrome; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Pyoderma Gangrenosum; Skin Ulcer | 2018 |
Successful treatment of PAPA syndrome with minocycline, dapsone, deflazacort and methotrexate: a cost-effective therapy with a 2-year follow-up.
Topics: Acne Vulgaris; Anti-Inflammatory Agents; Arthritis, Infectious; Cost-Benefit Analysis; Dapsone; Dermatologic Agents; Drug Therapy, Combination; Humans; Methotrexate; Minocycline; Pregnenediones; Pyoderma Gangrenosum; Skin | 2019 |
Pyoderma gangrenosum and tumor necrosis factor α agents.
Topics: Antibodies, Monoclonal; Crohn Disease; Dermatologic Agents; Etanercept; Humans; Immunoglobulin G; Infliximab; Male; Methotrexate; Middle Aged; Pyoderma Gangrenosum; Receptors, Tumor Necrosis Factor; Treatment Outcome; Tumor Necrosis Factor-alpha | 2013 |
Successful treatment of pyoderma gangrenosum associated with juvenile idiopathic arthritis with a combination of topical tacrolimus and oral prednisolone.
Topics: Administration, Oral; Administration, Topical; Adolescent; Arthritis, Juvenile; Humans; Immunosuppressive Agents; Male; Methotrexate; Prednisolone; Pyoderma Gangrenosum; Tacrolimus; Treatment Outcome; Ulcer | 2009 |
Skin lesions mimicking septic arthritis.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Arthritis, Infectious; Diagnosis, Differential; Female; Foot Dermatoses; Humans; Immunosuppressive Agents; Infliximab; Leg Dermatoses; Methotrexate; Middle Aged; Pyoderma Gangrenosum | 2006 |
Intravenous cyclophosphamide pulses in the treatment of pyoderma gangrenosum associated with rheumatoid arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclophosphamide; Female; Humans; Injections, Intravenous; Methotrexate; Pulsatile Flow; Pyoderma Gangrenosum | 1995 |
Treatment of pyoderma gangrenosum with methotrexate.
Topics: Adult; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Methotrexate; Prednisone; Pyoderma Gangrenosum; Recurrence; Wound Healing | 1996 |
Association between pyoderma gangrenosum and psoriasis.
Topics: Adult; Humans; Male; Methotrexate; Psoriasis; Pyoderma Gangrenosum; Silver Sulfadiazine; Triamcinolone | 1996 |